Plasma microrna quantification protocol

Sophie Maiocchi, Elizabeth N. Collins, Andrew Peterson, Kyle C Alexander, Dalton J. McGlamery, Noah A. Cassidy, John S. Ikonomidis, Adam W. Akerman
{"title":"Plasma microrna quantification protocol","authors":"Sophie Maiocchi, Elizabeth N. Collins, Andrew Peterson, Kyle C Alexander, Dalton J. McGlamery, Noah A. Cassidy, John S. Ikonomidis, Adam W. Akerman","doi":"10.20517/2574-1209.2023.69","DOIUrl":null,"url":null,"abstract":"MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate translation and are involved in many pathological processes. They have emerged as promising biomarkers for diagnosis of conditions such as aortic aneurysm disease. Quantifying miRNAs in plasma is uniquely challenging because of the lack of standardized reproducible protocols. To facilitate the independent verification of conclusions, it is necessary to provide a thorough disclosure of all pertinent experimental details. In this technical note, we present a comprehensive protocol for quantifying plasma miRNAs using droplet digital PCR. We detail the entire workflow, including blood collection, plasma processing, cryo-storage, miRNA isolation, reverse transcription, droplet generation, PCR amplification, fluorescence reading, and data analysis. We offer comprehensive guidance regarding optimization, assay conditions, expected results, and insight into the troubleshooting of common issues. The stepwise normalization and detailed methodological guide enhance reproducibility. Moreover, multiple portions of this protocol may be automated. The data provided in this technical note is demonstrative of the values typically obtained when following its steps. To facilitate standardization in data reporting, we include a table of expected aortic aneurysm-related miRNA levels in healthy human plasma. This versatile protocol can be easily adapted to quantify most circulating miRNAs in plasma, making it a valuable resource for diagnostic development.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vessel plus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/2574-1209.2023.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate translation and are involved in many pathological processes. They have emerged as promising biomarkers for diagnosis of conditions such as aortic aneurysm disease. Quantifying miRNAs in plasma is uniquely challenging because of the lack of standardized reproducible protocols. To facilitate the independent verification of conclusions, it is necessary to provide a thorough disclosure of all pertinent experimental details. In this technical note, we present a comprehensive protocol for quantifying plasma miRNAs using droplet digital PCR. We detail the entire workflow, including blood collection, plasma processing, cryo-storage, miRNA isolation, reverse transcription, droplet generation, PCR amplification, fluorescence reading, and data analysis. We offer comprehensive guidance regarding optimization, assay conditions, expected results, and insight into the troubleshooting of common issues. The stepwise normalization and detailed methodological guide enhance reproducibility. Moreover, multiple portions of this protocol may be automated. The data provided in this technical note is demonstrative of the values typically obtained when following its steps. To facilitate standardization in data reporting, we include a table of expected aortic aneurysm-related miRNA levels in healthy human plasma. This versatile protocol can be easily adapted to quantify most circulating miRNAs in plasma, making it a valuable resource for diagnostic development.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血浆微核定量方案
微小核糖核酸(miRNA)是一种非编码 RNA 小分子,可调节翻译并参与许多病理过程。它们已成为诊断主动脉瘤等疾病的有前途的生物标志物。由于缺乏标准化的可重现方案,血浆中 miRNAs 的定量具有独特的挑战性。为了便于独立验证结论,有必要彻底披露所有相关的实验细节。在本技术报告中,我们介绍了利用液滴数字 PCR 定量血浆 miRNA 的综合方案。我们详细介绍了整个工作流程,包括血液采集、血浆处理、低温储存、miRNA 分离、反转录、液滴生成、PCR 扩增、荧光读数和数据分析。我们提供有关优化、检测条件、预期结果的全面指导,并深入分析常见问题的排除方法。逐步归一化和详细的方法指南提高了重现性。此外,本方案的多个部分都可实现自动化。本技术说明中提供的数据是按照其步骤通常获得的数值。为便于数据报告的标准化,我们还附上了健康人血浆中主动脉瘤相关 miRNA 水平的预期值表。这种多用途方案很容易调整,可用于定量血浆中大多数循环 miRNA,因此是诊断开发的宝贵资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
0
期刊最新文献
Echocardiographic cardiac views classification using whale optimization and weighted support vector machine Association of inflammation, oxidative stress, and deteriorated cognitive functions in patients after cardiac surgery Role of inflammation in the progression of diabetic kidney disease Multivessel disease in patient with acute myocardial infarction: current treatment strategies and future perspectives Editorial review: guidance for future atrial fibrillation research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1